Pharmaceutical Supply Network is a complex architecture. The clinical phase organizations must ensure that their supply network is reliable and flexible to support the post-launch commercial supply chains to meet the finished product market demand. Many supplier viability, capacity, quality, technical and environmental risks that may severely affect the supply of the APIs, drug products and the finished products. The upcoming commercial organizations, without much leverage, must deal with the contract manufacturers and suppliers to reserve the manufacturing capacities and ensure shorter supply cycle-times.
SCMiND team brings deep knowledge of Pharmaceutical Supply Network - from large, global to mid and small size supply chains. We assist our clients in developing an efficient and reliable supply network design to mitigate the business continuity and product availability risks. We understand the CMO, CPO and 3PL capabilities that are critical for the end-to-end supply network.
SCMiND Supply Network Design methodology takes a deeper look at the current state of the supply network, analyzes the potential supply risks, defines the risk mitigation plans and recommends a comprehensive future state supply network design optimization options to support the long-term market growth.